AT327004T
Human anti-cd40 antibodies
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
53 members in 10 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 23755600 | United States of America | P |
Members53
| Document | Office | Kind | |
|---|---|---|---|
| CA2424296A1 | Canada | A1 | |
| CA2424749A1 | Canada | A1 | |
| WO0228480A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0228481A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0228904A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0228905A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU1136602A | Australia | A | |
| AU9650701A | Australia | A | |
| AU9654501A | Australia | A | |
| AU9654701A | Australia | A | |
| WO0228905A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0228480A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0228904A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0228481A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1322383A2 | European Patent Office (EPO) | A2 | |
| WO0228481A9 | World Intellectual Property Organization (WIPO) | A9 | |
| EP1326896A2 | European Patent Office (EPO) | A2 | |
| JP2004510752A | Japan | A | |
| US2004109857A1 | United States of America | A1 | |
| JP2004517611A | Japan | A | |
| EP1322383B1 | European Patent Office (EPO) | B1 | |
| AT327004TThis record | Austria | T | |
| ATE327004T1 | Austria | T1 | |
| DE60119945D1 | Germany | D1 | |
| EP1322383B9 | European Patent Office (EPO) | B9 | |
| EP1717251A2 | European Patent Office (EPO) | A2 | |
| DE60119945T2 | Germany | T2 | |
| US7288252B2 | United States of America | B2 | |
| EP1717251A3 | European Patent Office (EPO) | A3 | |
| US2008075727A1 | United States of America | A1 | |
| JP2008074870A | Japan | A | |
| JP2008156339A | Japan | A | |
| US7445780B2 | United States of America | B2 | |
| JP4202127B2 | Japan | B2 | |
| JP2009019046A | Japan | A | |
| US2009081242A1 | United States of America | A1 | |
| JP4271440B2 | Japan | B2 | |
| JP2009201523A | Japan | A | |
| US7611708B2 | United States of America | B2 | |
| US2010172912A1 | United States of America | A1 | |
| US7820170B2 | United States of America | B2 | |
| EP1326896B1 | European Patent Office (EPO) | B1 | |
| AT489403T | Austria | T | |
| ATE489403T1 | Austria | T1 | |
| DE60143535D1 | Germany | D1 | |
| US2011033456A1 | United States of America | A1 | |
| PT1326896E | Portugal | E | |
| ES2357051T3 | Spain | T3 | |
| JP4838831B2 | Japan | B2 | |
| US8088383B2 | United States of America | B2 | |
| EP1717251B1 | European Patent Office (EPO) | B1 | |
| AT541860T | Austria | T | |
| ATE541860T1 | Austria | T1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 1977428
Titles2
- German
- VERFAHREN ZUR THERAPIE VON B-ZELLMALIGNITÄTEN UNTER VERWENDUNG VON ANTAGONISTISCHEN ANTIKÖRPERN GEGEN CD40
- English
- METHOD FOR THE THERAPY OF B-CELL MALIGNITIES USING ANTAGONISTIC ANTIBODIES TO CD40
Classification
- CPC, 22
- C07K16/2878
- A01K2217/05
- A61K2039/505
- A61P1/00
- C07K2317/21
- A61P1/04
- C12N2799/026
- A61P1/16
- A61P7/02
- A61P7/04
- A61P17/06
- A61P19/02
- A61P25/00
- A61P29/00
- A61P35/00
- A61P35/02
- A61P35/04
- A61P37/00
- A61P37/02
- A61P37/06
- A61P37/08
- A61P43/00
- IPC, 17
- A61K39 395
- A61P1 04
- A61P17 06
- A61P19 02
- A61P25 00
- A61P29 00
- A61P35 00
- A61P37 00
- A61P37 02
- A61P37 06
- A61P43 00
- C07K16 18
- C07K16 28
- C07K16 30
- C12N15 09
- C12N15 13
- C12P21 08